Approval · Notice of Compliance 9349 · 2008
NORVIR: Notice of Compliance 9349
Issued January 31, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9349
- Date
- January 31, 2008
- Company
- Abbott Laboratories Co.Saint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Updates to the product monograph
- Therapeutic class
- Human immunodeficiency virus (HIV) protease inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NORVIR | Not yet assigned | — |
| NORVIR SEC | Not yet assigned | — |